Form 4: Iradimed CFO John Glenn Reports Stock Transactions

John Glenn, CFO of Iradimed Corp, reports the vesting of restricted stock units and subsequent stock transactions.

Summary

• On June 20, 2024, John Glenn, the CFO of Iradimed Corporation, had 5,796 restricted stock units (RSUs) vest, which converted into 5,796 shares of common stock.
• Glenn also disposed of 1,412 shares of common stock to cover tax obligations at a price of $42.53 per share.
• Following these transactions, Glenn directly owns 8,767 shares of common stock.
• Glenn also owns 11,592 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested in three equal annual installments beginning on December 11, 2025.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is a common practice in publicly traded companies. It provides transparency to investors regarding the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect insider activity, which is closely monitored by investors.

Key Dates

Keywords

IRADIMED CORP, IRMD, John Glenn, CFO, Form 4, Stock, RSU, Vesting, Transaction